Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdfd23399f7df989bc6a9fc1cd9585ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a7ebd2ce5ef7e691bd44c48a88a2bfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c273e0d5d9b45c0fac4961ffd3befb24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5dd388a5130b0bdede0fdfc6c2af6ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d6c80047adf3e21e4327a84eeae5176 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b785ce67a1f59f3883a093136ca58944 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70514 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_147a25f71a2ba2d2419ed02555aaaeac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_454814349d92b64d8734747b606e7beb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_446e62dba69c57ab81a05e948e3db89e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93de3d12a10aa0f1c2bff20510ef2499 |
publicationDate |
2014-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8647822-B2 |
titleOfInvention |
Determining whether a test compound modulates PD-1 activity in activated immune cells using gene expression profiles |
abstract |
Modulation of PD-1 activity in the presence or absence of an agent as measured by a gene expression profile of at least two genes is provided. Reagents, kits, methods and uses thereof for the modulation of immune function comprise the identification of modulators of PD-1 activity. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211614-A1 |
priorityDate |
2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |